- Investing Ideas
- /
- Danish Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals
Danish Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals
Results
2
0 new
High return on equity, past performance and sound balance sheet.
2 companies
ChemoMetec
Market Cap: DKK 9.0b
Engages in the development, production, and sale of analytical equipment for cell counting and analysis the United States, Canada, Europe, and internationally.
CHEMM
DKK 517.00
7D
0.9%
1Y
39.7%
Genmab
Market Cap: DKK 92.1b
A biotechnology company, develops antibody-based products and product candidates for the treatment of cancer and other diseases in Denmark.
GMAB
DKK 1,497.50
7D
7.6%
1Y
-23.0%